A Study of VLX1570 and Dexamethasone in Myeloma Patients
Status:
Terminated
Trial end date:
2017-05-24
Target enrollment:
Participant gender:
Summary
This is a phase 1/2 single arm study to determine the safety and efficacy of VLX1570 IV
infusion administered with low dose dexamethasone in patients with relapsed or relapsed and
refractory multiple myeloma.